# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Gregory Renza reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and maintains $3 price t...
Jones Trading analyst Justin Walsh maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target fro...
RBC Capital analyst Gregory Renza initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Outperform rating and an...